0001104659-21-032065.txt : 20210304
0001104659-21-032065.hdr.sgml : 20210304
20210304150840
ACCESSION NUMBER: 0001104659-21-032065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210304
DATE AS OF CHANGE: 20210304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDREWS RONALD ASBURY
CENTRAL INDEX KEY: 0001299153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36439
FILM NUMBER: 21713843
MAIL ADDRESS:
STREET 1: 5791 VAN ALLEN WAY
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER NAME:
FORMER CONFORMED NAME: Andrews Ronald Asbury
DATE OF NAME CHANGE: 20040730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Precipio, Inc.
CENTRAL INDEX KEY: 0001043961
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 911789357
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12325 EMMET ST
CITY: OMAHA
STATE: NE
ZIP: 68164
BUSINESS PHONE: 203 787 7888
MAIL ADDRESS:
STREET 1: 4 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSGENOMIC INC
DATE OF NAME CHANGE: 20000119
4
1
tm215617d2_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-03-01
0
0001043961
Precipio, Inc.
PRPO
0001299153
ANDREWS RONALD ASBURY
C/O PRECIPIO, INC., 4 SCIENCE PARK
NEW HAVEN
CT
06511
1
0
0
0
Employee Stock Option (right to buy)
2.60
2021-03-01
4
A
0
2069
0
A
2031-03-01
Common Stock
2069
2069
D
Employee Stock Option (right to buy)
2.60
2021-03-01
4
A
0
5171
0
A
2031-03-01
Common Stock
5171
5.171
D
On March 1, 2021 (the "Effective Date"), Mr. Ron A. Andrews (the "Reporting Person") was appointed to the Board of Directors of Precipio, Inc. (the "Company"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an "Option" and together, the "Options") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date).
The Option vests in twelve equal monthly installments beginning on the Effective Date.
The Option vests in thirty-six equal monthly installments beginning on the Effective Date.
/s/ Ron A Andrews
2021-03-04